Search company, investor...


Founded Year



Acquired | Acquired

Total Raised



GILUPI is a medical device company with focus on the development and production of products for the in vivo isolation of circulating tumor cells (CTCs). The GILUPI CellCollector consists of a thin, gold-coated stainless steel wire. The tip is coated with a biocompatible hydrogel with bound antibodies which are specifically directed against surface proteins of CTC. Once CTCs flow by, they are bound to the antibodies and can be isolated from the blood of the patient for further diagnosis.

Headquarters Location

Hermannswerder 20a

Potsdam, D-14473,


+49 331-5818478-2

Missing: GILUPI's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: GILUPI's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing GILUPI

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

GILUPI is included in 3 Expert Collections, including Cancer.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

GILUPI Patents

GILUPI has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Fluid dynamics, Bioinformatics, Aerodynamics, Fluid mechanics, DNA


Application Date


Grant Date



Related Topics

Fluid dynamics, Bioinformatics, Aerodynamics, Fluid mechanics, DNA



GILUPI Frequently Asked Questions (FAQ)

  • When was GILUPI founded?

    GILUPI was founded in 2005.

  • Where is GILUPI's headquarters?

    GILUPI's headquarters is located at Hermannswerder 20a, Potsdam.

  • What is GILUPI's latest funding round?

    GILUPI's latest funding round is Acquired.

  • How much did GILUPI raise?

    GILUPI raised a total of $4.8M.

  • Who are the investors of GILUPI?

    Investors of GILUPI include Hebei Viroad Biotechnology, High-Tech Grunderfonds, Brandenburg Kapital, Aurelia Private Equity and KfW.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.